Texas Oncology — Dallas, Texas

Public research footprint of Texas Oncology, compiled from the ClinicalTrials.gov public registry.

759

Registered studies

236

Active

117

Recruiting now

359

Completed

130

Stopped or withdrawn

Most-studied conditions

Breast Neoplasms · Resectable Pancreatic Ductal Adenocarcinoma (PDAC) · Metastatic Non-Small-Cell Lung Cancer · Carcinoma, Non-Small-Cell Lung

Recently updated registry entries

NCT07185997 — Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's… (Recruiting)
NCT06997497 — A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People… (Recruiting)
NCT06841354 — A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Texas Oncology?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.